Prolonged ADT for Prostate Cancer May Increase Risk of CV Mortality

Prolonged androgen deprivation therapy (ADT) was found to impair cardiorespiratory fitness and increase risk of cardiovascular (CV) mortality in prostate cancer patients with CV risk factors, according to a study in JACC: CardioOncology. ADT is a standard treatment for prostate cancer. This study, conducted by researchers from Brigham and Women’s Hospital and the Dana Farber … Continue reading Prolonged ADT for Prostate Cancer May Increase Risk of CV Mortality